Search results
Results from the WOW.Com Content Network
The full chapter can be found on pages 101 to 144 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1. Both volumes can be downloaded for free from the website of the World Health Organization. See here for a tabular overview of primary, secondary, in situ, and benign neoplasms.
It covers ICD codes 320 to 389. The full chapter can be found on pages 215 to 258 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1. Both volumes can be downloaded for free from the website of the World Health Organization.
List of ICD-9 codes 140–239: neoplasms; List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders; List of ICD-9 codes 280–289: diseases of the blood and blood-forming organs; List of ICD-9 codes 290–319: mental disorders; List of ICD-9 codes 320–389: diseases of the nervous system and sense organs
These medications can be employed to target specific systems in patients, or the cancer cells themselves. The wide variety of available drugs have varying impacts and side effects on a per-patient basis. [14] One of the most popular examples of drug-based management is immunotherapy, which bolsters the patient’s immune system to fight
The International Classification of Diseases for Oncology (ICD-O) is a domain-specific extension of the International Statistical Classification of Diseases and Related Health Problems for tumor diseases. This classification is widely used by cancer registries. It is currently in its third revision (ICD-O-3). ICD-10 includes a list of ...
A brain metastasis is a cancer that has metastasized (spread) to the brain from another location in the body and is therefore considered a secondary brain tumor. [ 1 ] [ 2 ] The metastasis typically shares a cancer cell type with the original site of the cancer. [ 3 ]
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
A theory was developed that the brain was likely a pharmacologic sanctuary where sub-clinical metastases were protected from cytotoxic drugs by the blood–brain barrier. Oncologists hypothesized that treatment of this sub-clinical disease with radiation therapy may stamp out the malignant process before it could advance to cause symptoms.